Click on a field for details on how to access that data via Web API, Excel, or CSV File Download.
| Open Price | |
| High Price | |
| Low Price | |
| Close Price | |
| Change | |
| Percent Change | |
| Volume |
| Avg Daily Volume | 190,245 |
| 52 Week High | $30.07 |
| 52 Week Low | $4.59 |
| Target Price | $27.62 |
| Ticker | NVCN:UW |
| Composite Ticker | NVCN:US |
| Security Name | Neovasc Inc |
| Type | Ordinary Shares |
| Class | NVCN |
| Currency | USD |
| Round Lot Size | 100 |
| Primary | Yes |
| Delisted | Yes |
| ETF | No |
| Market Category | Common Stock |
| Market Sector | Equity |
| Exchange Symbol | ^USCOMP |
| Exchange Name | US COMPOSITE |
| Exchange City | N/A |
| Exchange Country | UNITED STATES OF AMERICA |
| Exchange Website | N/A |
| FIGI | BBG000H13120 |
| Composite FIGI | BBG000H11ST4 |
| Share Class FIGI | BBG001S63XF1 |
| FIGI Unique ID | N/A |
| Dividend | N/A |
| Dividend Rate | N/A |
| Trailing Dividend Yield | 0.00% |
| 5-year Average Dividend Yield | 0.00% |
| Dividend Ex Date | 2022-04-29 |
| Beta | 2.8446 |
| 1-year beta | 4.5767 |
| 3-year beta | 2.8446 |
| 5-year beta | 1.3328 |
| 7-year beta | 1.5022 |
| 10-year beta | 1.299 |
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
